Case series:???

3 trials

Sponsors

Chinese People's Liberation Army Bayi Hospital, Jiangsu Province Hospital, Guangxi Medical University Cancer Hospital

Conditions

GCB type diffuse large B-cell lymphomaLung canceradvanced ovarian cancer

Phase 1

the treatment of YY-20394 for patients with relapsed and/or refractory GCB diffuse large B-cell lymphoma: A single-arm, open, single-center phase 1b clinical trial

RecruitingChiCTR2000038625

Guangxi Medical University Cancer HospitalGCB type diffuse large B-cell lymphoma

Start: 2020-09-28Updated: 2020-12-07

Phase 4

An observational clinical study for Camrelizumab in the treatment of inoperable lung cancer

Active, not recruitingChiCTR1900026089

Jiangsu Province HospitalLung cancer

Start: 2019-10-01Updated: 2019-10-21

Unknown Phase

Targeting mesothelin chimeric antigen receptor modified autologous T cells for advanced ovarian cancer clinical research

RecruitingChiCTR1800016764

Chinese People's Liberation Army Bayi Hospitaladvanced ovarian cancer

Start: 2018-07-01Updated: 2018-06-25

Related Papers

Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101)

Translational Lung Cancer Research2023-04-018 citations

Camrelizumab in the treatment of patients with advanced lung cancer: A multicenter, prospective, cohort study.

Journal of Clinical Oncology2020-05-203 citations